Tissue Repair Intangible Assets

What does Tissue Repair do? Tissue Repair Ltd. develops advanced wound healing products for chronic wounds and post-cosmetic procedure care. The company is in the final stages of completing its Phase II program for TR-987, a chronic wound product, and concluded Phase IIB trials on Glucoprime, a proprietary molecule. TR Pro+ is the firm's cosmeceutical post-procedure gel product used in minimally invasive cosmetic procedures, currently focused on commercialization. The company's revenue streams include product development for TR-987, Glucoprime, and TR Pro+. Tissue Repair Ltd. targets healthcare providers and cosmetic clinics as key buyers of its products. Healthcare providers use TR-987 for chronic wound management, while cosmetic clinics utilize TR Pro+ for post-procedure care. The firm's focus on commercialization of TR Pro+ indicates a direct sales approach to these segments. The company's pipeline includes TR-987, Glucoprime, and TR Pro+ as its core products. The firm's products are developed for specific medical and cosmetic segments. TR-987 addresses chronic wound healing, a significant healthcare need, while Glucoprime is a proprietary molecule with potential for further development. TR Pro+ serves the growing cosmeceutical market for post-procedure care. The company's business model relies on advancing its pipeline through clinical trials and commercializing its products to target healthcare and cosmetic markets. Tissue Repair is one of the most popular companies on Eulerpool.